Abstract
Neurotransmitter assay of epinephrine (EP) was sought using a modified carbon nanotube paste electrode (PE). Using optimum conditions, cyclic voltammetry (CV) and the square wave (SW) stripping voltammetric working ranges were attained to 10-100 mgL-1 (CV) and 20-140 ngL-1 (SW). The relative standard deviation of 0.0549 (n=15) was obtained at 20.0 mgL-1 EP constant. Here, the analytical detection limit (S/N) was reached with 4.60 ngL-1 (2.5×10-11 molL-1) EP. The hand-made electrode was implanted into the in-vivo brain core of the animals and was used in chronoamperometric neuro detection. The results obtained are applicable in neuro sensing, physiological control, and other neuroscience fields.
Keywords: Epinephrine, neuro sens, electrochemical, brain, in vivo, interface.
Current Neurovascular Research
Title:Implementation of a Biocircuit Implants for Neurotransmitter Release During Neuro-Stimulation
Volume: 10 Issue: 3
Author(s): Suw Young Ly and Dal woong Choi
Affiliation:
Keywords: Epinephrine, neuro sens, electrochemical, brain, in vivo, interface.
Abstract: Neurotransmitter assay of epinephrine (EP) was sought using a modified carbon nanotube paste electrode (PE). Using optimum conditions, cyclic voltammetry (CV) and the square wave (SW) stripping voltammetric working ranges were attained to 10-100 mgL-1 (CV) and 20-140 ngL-1 (SW). The relative standard deviation of 0.0549 (n=15) was obtained at 20.0 mgL-1 EP constant. Here, the analytical detection limit (S/N) was reached with 4.60 ngL-1 (2.5×10-11 molL-1) EP. The hand-made electrode was implanted into the in-vivo brain core of the animals and was used in chronoamperometric neuro detection. The results obtained are applicable in neuro sensing, physiological control, and other neuroscience fields.
Export Options
About this article
Cite this article as:
Ly Young Suw and Choi woong Dal, Implementation of a Biocircuit Implants for Neurotransmitter Release During Neuro-Stimulation, Current Neurovascular Research 2013; 10 (3) . https://dx.doi.org/10.2174/15672026113109990017
DOI https://dx.doi.org/10.2174/15672026113109990017 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Towards an Evidence-based Model of Aging
Current Aging Science Leptin and Interleukin-1β Modulate Neuronal Glutamate Release and Protect Against Glucose-Oxygen-Serum Deprivation
Current Neurovascular Research Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design Circadian MicroRNAs in Cardioprotection
Current Pharmaceutical Design The Effects of Maternally Administered Methadone, Buprenorphine and Naltrexone on Offspring: Review of Human and Animal Data
Current Neuropharmacology The Hypothalamic-Pituitary-Adrenal Axis: What can it Tell us About Stressors?
CNS & Neurological Disorders - Drug Targets The Effects of Physical and Psychological Stress on the Gastrointestinal Tract: Lessons from Animal Models
Current Molecular Medicine Bone Mass Gain During Puberty and Adolescence: Deconstructing Gender Characteristics
Current Medicinal Chemistry ATP-Sensitive Potassium Channels
Current Pharmaceutical Design Aripiprazole: A Drug with a Novel Mechanism of Action and Possible Efficacy for Alcohol Dependence
CNS & Neurological Disorders - Drug Targets Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications
Current Neuropharmacology Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Topical Calcineurin Inhibitors, Pimecrolimus and Tacrolimus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Blood-Brain Barrier as a Cause of Obesity
Current Pharmaceutical Design Gestational Exposure to Variable Stressors Produces Decrements in Cognitive and Neural Development of Juvenile Male and Female Rats
Current Topics in Medicinal Chemistry Targeting Gender Difference in the Introduction of New Drugs for Diabetes Mellitus and Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Advancement in Obesity Management: Leptin and Adiponectin Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications
CNS & Neurological Disorders - Drug Targets Emerging Role for RBM20 and its Splicing Substrates in Cardiac Function and Heart Failure
Current Pharmaceutical Design Discovery of New Cardiovascular Hormones for the Treatment of Congestive Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets